Pay in 4 interest-free payments of $23.80 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
ClH/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25
Dexamethasone treatment has been shown to strongly stimulate the level of the Id-1 protein
caused by either genetic or small-molecule inhibition of G9a
InChi: InChI=1S/C13H26O4/c1-2-3-4-5-6-7-8-9-13(16)17-11-12(15)10-14/h12
When LnCaP cells are pretreated with AKT-IN-VIII and then incubated with TRAIL
Sorafenib Tosylate - CAS# 475207-59-1 rizine dihydrochloride ClH/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25Sorafenib, also known as BAY 43 9006, is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF MEK ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR 2 PDGFR beta signaling cascade, thereby blocking tumor angiogenesis. Sorafenib was approved in 2005 for use in the treatment of advanced renal cancer. Product
US$ 4633.81
US$ 4385.09
US$ 4731.37
US$ 949.06
US$ 67.20
US$ 79.95